ALNY Alnylam Pharmaceuticals, Inc.

HealthcareBiotechnology
$295.91
▼ 2.34%
42
QScore Signal
Hold
Confidence: MEDIUM
Long-Term
41
Short-Term
43

Value

11
P/E68.13
0
P/B36.57
22
P/S9.22
27
EV/EBITDA63.67
0

Growth

84
Revenue Growth65.2%
100
EPS Growth209.6%
57
FCF Growth1192.7%
100

Momentum

44
12-Month Return9.7%
54
3-Month Return-10.7%
43
1-Month Return-9.6%
36
RSI (14)39.15
50
50/200 MABearish
30

Profitability

53
ROE98.3%
70
ROA11.3%
62
Gross Margin80.9%
66
Operating Margin17.5%
45
Net Margin13.5%
47
FCF Yield1.6%
23

Risk

28
Beta0.30
35
60-Day Volatility36.7%
22

Generated 5/7/2026, 10:02:10 PM · How is this calculated?

QScore Analysis